Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV-1 | 13 | 2023 | 6863 | 1.030 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 3 | 2015 | 369 | 0.870 |
Why?
|
HIV Infections | 16 | 2023 | 17352 | 0.700 |
Why?
|
Viral Envelope Proteins | 4 | 2013 | 640 | 0.690 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4580 | 0.510 |
Why?
|
Integrins | 2 | 2013 | 834 | 0.400 |
Why?
|
Genome, Viral | 2 | 2018 | 667 | 0.400 |
Why?
|
Anti-Retroviral Agents | 3 | 2023 | 1784 | 0.380 |
Why?
|
Withholding Treatment | 3 | 2021 | 617 | 0.350 |
Why?
|
Substance Abuse, Intravenous | 1 | 2014 | 529 | 0.340 |
Why?
|
Genetic Variation | 2 | 2015 | 6567 | 0.330 |
Why?
|
Dengue Virus | 2 | 2008 | 201 | 0.330 |
Why?
|
Pichia | 1 | 2008 | 49 | 0.310 |
Why?
|
Polymerase Chain Reaction | 2 | 2015 | 6075 | 0.290 |
Why?
|
Receptors, CCR5 | 1 | 2009 | 486 | 0.280 |
Why?
|
Antigens, Viral | 2 | 2008 | 988 | 0.280 |
Why?
|
Proviruses | 4 | 2023 | 313 | 0.280 |
Why?
|
RNA, Viral | 4 | 2023 | 2846 | 0.240 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2023 | 4369 | 0.230 |
Why?
|
Antibodies, Neutralizing | 3 | 2023 | 1943 | 0.220 |
Why?
|
Viremia | 2 | 2023 | 707 | 0.210 |
Why?
|
Fetal Distress | 1 | 2022 | 39 | 0.200 |
Why?
|
HIV Antibodies | 4 | 2023 | 1303 | 0.190 |
Why?
|
Fetal Death | 1 | 2022 | 435 | 0.170 |
Why?
|
Antibodies, Viral | 2 | 2008 | 3156 | 0.170 |
Why?
|
Viral Load | 5 | 2023 | 3332 | 0.160 |
Why?
|
Receptors, HIV | 2 | 2016 | 159 | 0.150 |
Why?
|
Virus Replication | 3 | 2016 | 2435 | 0.150 |
Why?
|
HIV Seropositivity | 1 | 2023 | 960 | 0.150 |
Why?
|
Neutralization Tests | 3 | 2016 | 728 | 0.150 |
Why?
|
HIV Long-Term Survivors | 1 | 2018 | 121 | 0.150 |
Why?
|
Genotype | 4 | 2021 | 12990 | 0.130 |
Why?
|
Anti-HIV Agents | 3 | 2021 | 4527 | 0.120 |
Why?
|
Cytological Techniques | 1 | 2016 | 218 | 0.120 |
Why?
|
Drug Resistance, Viral | 2 | 2021 | 862 | 0.120 |
Why?
|
CD4 Lymphocyte Count | 2 | 2017 | 2571 | 0.120 |
Why?
|
Dengue | 2 | 2008 | 254 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2201 | 0.110 |
Why?
|
Remission Induction | 1 | 2019 | 2397 | 0.110 |
Why?
|
RNA | 1 | 2023 | 2726 | 0.110 |
Why?
|
Cell Line | 3 | 2015 | 15601 | 0.110 |
Why?
|
Placenta | 1 | 2022 | 1709 | 0.100 |
Why?
|
Lymphocyte Activation | 1 | 2023 | 5485 | 0.100 |
Why?
|
Immunity, Humoral | 1 | 2016 | 606 | 0.100 |
Why?
|
Heterosexuality | 1 | 2013 | 309 | 0.100 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 727 | 0.090 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 803 | 0.090 |
Why?
|
Virulence | 1 | 2014 | 1303 | 0.090 |
Why?
|
Serotyping | 2 | 2008 | 325 | 0.090 |
Why?
|
Gastric Mucosa | 1 | 2013 | 604 | 0.090 |
Why?
|
Glycosylation | 1 | 2013 | 1097 | 0.090 |
Why?
|
Antigens | 1 | 2016 | 1443 | 0.090 |
Why?
|
Immunity, Mucosal | 1 | 2013 | 483 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 2151 | 0.090 |
Why?
|
Dengue Vaccines | 1 | 2008 | 16 | 0.080 |
Why?
|
Family Characteristics | 1 | 2013 | 1004 | 0.080 |
Why?
|
Inhibitory Concentration 50 | 1 | 2009 | 465 | 0.080 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2008 | 364 | 0.080 |
Why?
|
Culicidae | 1 | 2008 | 108 | 0.080 |
Why?
|
Haplorhini | 1 | 2008 | 525 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1459 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 8002 | 0.060 |
Why?
|
Humans | 21 | 2023 | 761572 | 0.060 |
Why?
|
Mutation, Missense | 1 | 2014 | 2571 | 0.060 |
Why?
|
Binding Sites | 1 | 2013 | 6056 | 0.060 |
Why?
|
Cricetinae | 1 | 2008 | 2423 | 0.060 |
Why?
|
Monocytes | 2 | 2012 | 2570 | 0.060 |
Why?
|
Macrophages | 3 | 2021 | 5769 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4740 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2013 | 18965 | 0.050 |
Why?
|
Genetic Engineering | 1 | 2008 | 933 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2022 | 143 | 0.050 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3792 | 0.050 |
Why?
|
Spleen | 1 | 2008 | 2295 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2008 | 6214 | 0.050 |
Why?
|
Antiviral Agents | 1 | 2014 | 3060 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17635 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13446 | 0.050 |
Why?
|
Kinetics | 1 | 2009 | 6374 | 0.050 |
Why?
|
Chorioamnionitis | 1 | 2022 | 156 | 0.050 |
Why?
|
Viral Vaccines | 1 | 2006 | 596 | 0.040 |
Why?
|
Glycomics | 1 | 2021 | 113 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2008 | 3733 | 0.040 |
Why?
|
HIV Envelope Protein gp120 | 2 | 2016 | 914 | 0.040 |
Why?
|
Virus Activation | 1 | 2021 | 322 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 706 | 0.040 |
Why?
|
Coculture Techniques | 2 | 2013 | 1341 | 0.040 |
Why?
|
Cohort Studies | 3 | 2021 | 41493 | 0.040 |
Why?
|
Defective Viruses | 1 | 2018 | 89 | 0.040 |
Why?
|
Disease Reservoirs | 1 | 2018 | 121 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14607 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1230 | 0.040 |
Why?
|
Phenotype | 1 | 2015 | 16592 | 0.030 |
Why?
|
Viral Tropism | 1 | 2016 | 102 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2022 | 1351 | 0.030 |
Why?
|
DNA, Viral | 1 | 2021 | 2202 | 0.030 |
Why?
|
Protein Binding | 2 | 2016 | 9353 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2811 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9469 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 432 | 0.030 |
Why?
|
Plasma | 1 | 2016 | 586 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2022 | 2917 | 0.030 |
Why?
|
Metabolomics | 1 | 2021 | 1659 | 0.020 |
Why?
|
Dendritic Cells | 2 | 2013 | 2747 | 0.020 |
Why?
|
Female | 7 | 2023 | 392686 | 0.020 |
Why?
|
Cell-Free System | 1 | 2012 | 340 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4544 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2008 | 10194 | 0.020 |
Why?
|
Male | 6 | 2023 | 360842 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2013 | 868 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2016 | 1844 | 0.020 |
Why?
|
Mice | 3 | 2016 | 81533 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12463 | 0.020 |
Why?
|
Mutation | 2 | 2021 | 30054 | 0.020 |
Why?
|
Adult | 4 | 2022 | 221203 | 0.020 |
Why?
|
Animals | 3 | 2016 | 168467 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8466 | 0.010 |
Why?
|
Vaccines, Synthetic | 1 | 2006 | 616 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12690 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10773 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 220920 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29876 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6534 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2012 | 9177 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 39970 | 0.010 |
Why?
|
Escherichia coli | 1 | 2006 | 4217 | 0.010 |
Why?
|
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_